Improved loss from operations by 31% - - Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health ...
Company to Host Conference Call Today at 8:30 a.m. EDT-- DUBLIN and CHICAGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), (Iterum), a company focused on delivering next ...
Research and development (R&D) expenses for the third quarter 2024 were $3.1 million compared to $14.9 million for the same period in 2023. The decrease for the three-month period was primarily due to ...
Preventing bacterial infections to protect heart valvesAntibiotic prophylaxis: In the past, doctors used to recommend antibiotic prophylaxis before some kinds of medical or dental procedures like ...
After decades of unrelenting increases, rates of sexually transmitted infections in the United States are showing hints of a downturn ... likely to be an early signal of such men’s eager adoption of a ...